‘The most remarkable change has been Jio’
Netflix boss Reed Hastings on the Jio effect on data prices in India, his ‘no rules’ management philosophy, the India growth strategy, and more. A Fortune India exclusive.
lupin
February 2021
November 2020
September 2019
August 2018
November 2017
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
The toughest period is behind us: Vinita Gupta
India’s third-largest generic drugmaker Lupin is focussing on building a pipeline of specialty drugs, while cutting costs and addressing regulatory concerns.
‘New complex generics to augur well for Lupin’
Vinita Gupta is confident that new complex generics, specialty drugs and manufacturing quality enhancement plan will augur well for the company
US business remains Sun Pharma’s weak spot
US sales have dropped to less than a third of overall revenue from nearly half five years ago and profits have taken a beating despite cost synergies after the acquisition of Ranbaxy Laboratories.
